Filter
2293
Text search:
sars
Featured
320
67
Language
Document type
838
392
331
163
135
110
101
71
43
40
34
23
12
Countries / Regions
161
133
93
90
89
78
61
59
50
48
47
45
43
40
36
36
34
33
33
28
28
28
27
25
24
23
23
19
19
18
18
18
17
16
16
14
13
12
12
12
12
12
11
11
11
10
10
10
10
10
9
9
9
8
8
8
8
8
7
7
6
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
1135
57
51
43
31
29
22
2
1
Toolboxes
1737
80
62
48
36
35
31
30
20
18
17
11
11
11
10
9
8
8
8
4
3
3
Analysis of fake news disseminated during the COVID-19 pandemic in Brazil
Coding of causes of death mentioning Multisystemic Inflammatory Syndrome associated with coronavirus disease
Esta orientação provisória foi desenvolvida com base na recomendação emitida pelo Grupo Consultivo Estratégico de Especialistas (SAGE) em imunização, em sua reunião extraordinária de 5 de janeiro de 2021, e atualizada durante sua reunião extraordinária de 27 de maio de 2021 (2), sendo no
...
This bi-weekly brief details the latest developments in scientific knowledge and public health policy from around the world as well as updates to the COVID-19-related guidance from Africa CDC, WHO and other public health agencies.
Brazilian media and science communicators must understand the main characteristics of misinformation in social media about COVID-19, so that they can develop attractive, up-to-date and evidence-based content that helps to increase health literacy and counteract the spread of false information.
The COVID-19 pandemic arrived in an evolving epidemiological context where some countries are experiencing a progressive decrease in HIV positivity in their testing programme as they are moving closer to the first 95 target. Distinguishing changes in HIV testing services due to the COVID-19 pandemic
...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th
...
11 august 2022, updated version
La OMS ha elaborado una definición de caso clínico de la afección posterior a la COVID-19 mediante la metodología Delphi que incluye 12 dominios, disponible para su uso en todos los entornos. Esta primera versión fue elaborada por pacientes, investigadores y otras personas, en representación d
...
The 2021 COVID-19 Strategic Preparedness and Response Plan (SPRP) for AFR serves as a regional guide for a holistic public health response to COVID‑19 at regional, national and sub-national levels. The 2021
SPRP:
1. Builds upon the lessons learnt from the implementation of the 2020 SPRP and outl
...
Existen notificaciones de eventos relacionados con la vacuna (ESAVI) de
miocarditis/pericarditis en adolescentes tras la administración de vacunas ARNm(Pfizer y Moderna) especialmente tras la segunda dosis. Al momento no seencuentra asociación entre la enfermedad y la administración de la vacuna
...
Consensual Recommendation for treatment of COVID-19 in older adults
Consensual recommendations for outpatient management and home care
and home treatment of patients with COVID-19
Vaccination against COVID-19 in Indigenous peoples and nationalities,
Afro-Ecuadorian and Montubio peoples and nationalities of Ecuador
Operational Guidelines
Recommendations on the management of diabetes mellitis during the COVID-19 pandemic
National Directorate for Environment and Health - Guidelines for the prevention of COVID-19 in elderly care workplaces
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Comirnaty® 10 μg und 30 μg von BioNTech / Pfizer und Spikevax® von Moderna
Stand 21. Dezember 2021
